These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 8571330)

  • 1. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Procoagulant nature of fibrin].
    Béguin S
    Bull Acad Natl Med; 1998; 182(7):1479-91; discussion 1491-2. PubMed ID: 9916342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy.
    Jen CJ; McIntire LV
    Thromb Haemost; 1986 Aug; 56(1):23-7. PubMed ID: 2877507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
    Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
    Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ; Eisenberg PR; Abendschein DR
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
    Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
    Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased thrombin activity of fibrin clots prepared in cord plasma compared with adult plasma.
    Patel P; Weitz J; Brooker LA; Paes B; Mitchell L; Andrew M
    Pediatr Res; 1996 May; 39(5):826-30. PubMed ID: 8726236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets.
    Lockhart MS; Comp PC; Taylor FB
    J Lab Clin Med; 1979 Aug; 94(2):285-94. PubMed ID: 458246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin network structure: modification by platelets.
    Dhall TZ; Shah GA; Ferguson IA; Dhall DP
    Thromb Haemost; 1983 Feb; 49(1):42-6. PubMed ID: 6845271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
    Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
    Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
    Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.
    Bendayan P; Boccalon H; Dupouy D; Boneu B
    Thromb Haemost; 1994 May; 71(5):576-80. PubMed ID: 8091383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL; Matsueda GR; Haber E
    Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.